1 (Duta)
Dutasteride And Tamsulosin Hydrochloride Capsule
Product Images NDC 42291-031
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dutasteride And Tamsulosin Hydrochloride (NDC 42291-031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Dutasteride-structural-formula.jpg (Dutasteride And Tamsulosin Hydrochloride 1)
Tamsulosin-structural-formula.jpg (Dutasteride And Tamsulosin Hydrochloride 2)
Spl\figure-1.jpg (Dutasteride And Tamsulosin Hydrochloride 3)
The text provided states the mean change from baseline in IPSS (International Prostate Symptom Score) for different treatment groups over several months. The first treatment group includes both Dutasteride and tamsulosin, with a sample size of 1,575. The second treatment group consists of Dutasteride 0.5 mg alone, with a sample size of 1,592. The third treatment group involves Tamsulosin 0.4 mg alone, with a sample size of 1,582. The data is provided for multiple months of treatment, but no specific values are given.*
Figure-2.jpg (Dutasteride And Tamsulosin Hydrochloride 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
